中文名稱(chēng)  磷酸化酪氨酸激酶受體A抗體規(guī)格 

英文名稱(chēng)  Anti-Phospho-TrkA (Tyr791)

別    名 TrkA (Phospho-Tyr791); TrkA (Phospho Tyr791); TrkA (Phospho-Y791); p-TrkA(Tyr791); CIPA; CIPA; DKFZp781I14186; gp140trk; High affinity nerve growth factor receptor; High affinity nerve growth factor receptor precursor; High affinity nerve growth factor receptor precursor; MTC; MTC; neurotrophic tyrosine kinase receptor type 1; neurotrophic tyrosine kinase receptor type 1; Ntrk 1; Ntrk1; Ntrk1; NTRK1_HUMAN; Oncogene TRK; Oncogene TRK; p140 TrkA; p140-TrkA; TRK 1; Trk A; TRK; TRK; Trk-A; TRK1; TRK1 transforming tyrosine kinase protein; TRK1-transforming tyrosine kinase protein; Tropomyosin-related kinase A; Tyrosine kinase receptor A; Tyrosine kinase receptor; Tyrosine Receptor Kinase A.

產(chǎn)品屬性：

磷酸化酪氨酸激酶受體A抗體規(guī)格 濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來(lái)源  Rabbit

克隆類(lèi)型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat

產(chǎn)品類(lèi)型   一抗 磷酸化抗體  

研究領(lǐng)域    細(xì)胞生物 免疫學(xué) 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 90kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human TrkA around the phosphorylation site of Tyr791

亞    型  IgG

純化方法   affinity purified by Protein A

儲(chǔ) 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

磷酸化酪氨酸激酶受體A抗體規(guī)格 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200

（石蠟切片需做抗原修復(fù)） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 The Trk family of nerve growth factor receptors includes Trk A(also referfed to as Trk A gp140),Trk B and Trk C. The prototype member of this gene family, Trk A, encodes a 140 kDa cell surface receptor , gp140, the expression of which is restricted in vivo to neurons of the sensory spinal and cranial gangliaof neurocrest origin. Nerve growth factor (NGF) stimulates tyrosine phosphorylation of Trk gp 140 in neural cell lines and in embryonic dorsal root ganglia. By comparison, BDNF and to a lesser extent, NT-3, but not NGF, can induce tyrosine phophorylayion of Trk B gp 145. The third member of the Trk receptor family, Trk C incodes a 140 kDa protein, Trk C gp140, that is preferentially expressed in brain tissue and primarily functions as a receptor for NT-3.An additional component of the Trk receptor complex, NGFR p175, binds to neurotrophic factors with low affinity but is required for efficient signaling. NGFR p175 accelerates Trk activation and may recruit downstream dffector molecules to the ligand-bound receptor complex.

Function : Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand, it can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival. Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors.

Isoform TrkA-III is resistant to NGF, constitutively activates AKT1 and NF-kappa-B and is unable to activate the Ras-MAPK signaling cascade. Antagonizes the anti-proliferative NGF-NTRK1 signaling that promotes neuronal precursors differentiation. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed.

Subunit : Exists in a dynamic equilibrium between monomeric (low affinity) and dimeric (high affinity) structures. Homodimerization is induced by binding of a NGF dimer. Interacts with SQSTM1; bridges NTRK1 to NGFR. Forms a ternary complex with NGFR and KIDINS220; this complex is affected by the expression levels of KIDINS220 and an increase in KIDINS220 expression leads to a decreased association of NGFR and NTRK1 (By similarity). Interacts with SH2D1A; regulates NTRK1 (By similarity). Interacts (phosphorylated upon activation by NGF) with SHC1; mediates SHC1 phosphorylation and activation. Interacts (phosphorylated upon activation by NGF) with PLCG1; mediates PLCG1 phosphorylation and activation. Interacts (phosphorylated) with SH2B1 and SH2B2. Interacts with GRB2. Interacts with PIK3R1. Interacts with FRS2. Interacts with SORT1; may regulate NTRK1 anterograde axonal transport. Interacts with RAB7A.

Subcellular Location : Cell membrane; Single-pass type I membrane protein. Early endosome membrane; Single-pass type I membrane protein. Note=Internalized to endosomes upon binding of NGF or NTF3 and further transported to the cell body via a retrograde axonal transport.

Tissue Specificity : Isoform TrkA-I is found in most non-neuronal tissues. Isoform TrkA-II is primarily expressed in neuronal cells. TrkA-III is specifically expressed by pluripotent neural stem and neural crest progenitors.

Post-translational modifications : Ligand-mediated autophosphorylation. Interaction with SQSTM1 is phosphotyrosine-dependent. Autophosphorylation at Tyr-496 mediates interaction and phosphorylation of SHC1.

N-glycosylated (Probable). Isoform TrkA-I is N-glycosylated.

Ubiquitinated. Undergoes polyubiquitination upon activation; regulated by NGFR. Ubiquitination regulates the internalization of the receptor (By similarity)

DISEASE : Defects in NTRK1 are a cause of congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]. CIPA is characterized by a congenital insensitivity to pain, anhidrosis (absence of sweating), absence of reaction to noxious stimuli, self-mutilating behavior, and mental retardation. This rare autosomal recessive disorder is also known as congenital sensory neuropathy with anhidrosis or hereditary sensory and autonomic neuropathy type IV or familial dysautonomia type II.

Defects in NTRK1 are a cause of thyroid papillary carcinoma (TPC) [MIM:188550]. TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. Note=Chromosomal aberrations involving NTRK1 are found in thyroid papillary carcinomas. Translocation t(1;3)(q21;q11) with TFG generates the TRKT3 (TRK-T3) transcript by fusing TFG to the 3'-end of NTRK1; a rearrangement with TPM3 generates the TRK transcript by fusing TPM3 to the 3'-end of NTRK1; an intrachromosomal rearrangement that links the protein kinase domain of NTRK1 to the 5'-end of the TPR gene forms the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting with antibodies against the C-terminus of the NTRK1 protein.

Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.

Contains 2 Ig-like C2-type (immunoglobulin-like) domains.

Contains 2 LRR (leucine-rich) repeats.

Contains 1 LRRCT domain.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: P04629.4

TrkA是NGF的功能性受體，當(dāng)其與NGF結(jié)合后，可激活酪氨酸激酶信號(hào)傳遞系統(tǒng)，從而啟動(dòng)，產(chǎn)生生物效應(yīng)。

實(shí)驗(yàn)流程：

全、新、優(yōu)、品、好四大特點(diǎn)：

磷酸化酪氨酸激酶受體A抗體規(guī)格 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢(xún)。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。

技術(shù)外包服務(wù):

★磷酸化酪氨酸激酶受體A抗體規(guī)格 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。

正在熱銷(xiāo)的相關(guān)產(chǎn)品：

Anti-H1N1-A/HRP(Influenza A virus)California 辣根過(guò)氧化物酶標(biāo)記兔抗季節(jié)性A型人病毒H1N1抗體IgG(美國(guó)加州型)Multi-class antibodies規(guī)格： 0.2ml

MT-II(Melanotan II Acetate) 醋酸美拉諾坦IIMulti-class antibodies規(guī)格： 1g

CD14/內(nèi)毒素受體抗體 Anti-CD14 0.1ml

SYVN1 英文名稱(chēng)： 滑膜細(xì)胞凋亡抑制物1抗體 0.1ml

EphA7 英文名稱(chēng)： 酪酸蛋白激酶受體A7抗體 0.2ml

Rhesus antibody Rh phospho-HDAC1(Ser423+Ser421) 磷酸化組蛋白去乙?；?抗體 規(guī)格 0.1ml

MT-II(Melanotan II Acetate) 醋酸美拉諾坦IIMulti-class antibodies規(guī)格： 1g

Anti-P-p38 ERK/MAPK14 /FITC 熒光素標(biāo)記磷酸化-原活化蛋白激酶p38抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Mouse Anti-human IgG Monoclonal Antibody/HRP 辣根過(guò)氧化物酶標(biāo)記小鼠抗人IgG單克隆抗體Multi-class antibodies規(guī)格： 0.1ml

致癌基因抗體 Anti-C-Myc/MYC/MTLC 0.1ml

Mouse Anti-Rabbit IgM/Alexa Fluor 488 Alexa Fluor 488標(biāo)記的小鼠抗兔IgM 0.1ml

Phospho-FOXO1 + FOXO3 + FOXO4 (phospho T24 + T32) 英文名稱(chēng)： 磷酸化叉頭蛋白家族抗體 0.1ml

Rhesus antibody Rh PILR beta 細(xì)胞表面受體PILRβ抗體 規(guī)格 0.2ml

Mouse Anti-human IgG Monoclonal Antibody/HRP 辣根過(guò)氧化物酶標(biāo)記小鼠抗人IgG單克隆抗體Multi-class antibodies規(guī)格： 0.1ml

P311 protein 相關(guān)蛋白(抗原)Multi-class antibodies規(guī)格： 0.5mg

Anti-CD54/ICAM-1 細(xì)胞間粘附分子-1抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh P38 MAPK(Phospho-Thr180/Tyr182) 磷酸化-原活化蛋白激酶p38抗體(P-p38 MAPK) 規(guī)格 0.1ml

IL1B Kit Human 人 IL-1 beta / IL1B / IL-1F2 ELISA配對(duì)抗體 ELISA

TUB 1 英文名稱(chēng)： TUB蛋白抗體 0.2ml

COBL 英文名稱(chēng)： -綜合征相關(guān)COBL蛋白抗體 0.1ml

Anti-CD54/ICAM-1 細(xì)胞間粘附分子-1抗體Multi-class antibodies規(guī)格： 0.1ml

FASLG Protein Human 重組人 Fas Ligand / FASLG / CD95L 蛋白 (His 標(biāo)簽)

CNE-2 低分化細(xì)胞

ICOS Others Mouse 小鼠 ICOS / AILIM / CD278 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

BxPC-3人原位*腺癌細(xì)胞 BxPC-3 in situ pancreatic adenocarcinoma cells 1640+10% FBS

小鼠細(xì)胞(分泌促生長(zhǎng)激素分泌激素);AtT-20

人成纖維細(xì)胞( HCF) ( 5×105 ) GC-1, 鼠精原細(xì)胞 Mouse

CL-0456TM4(正常小鼠Sertoli細(xì)胞)5×106cells/瓶×2

SIGIRR Others Human 人 SIGIRR / TIR8 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

人膀胱基質(zhì)成纖維細(xì)胞RNAHBdSF miRNA5 μg

T24細(xì)胞，人膀胱移行細(xì)胞癌細(xì)胞 大鼠細(xì)胞(wistar 大鼠),CBRH7919細(xì)胞 RN-c, 大鼠皮質(zhì)神經(jīng)元

Ishikawa(人細(xì)胞) 5×106cells/瓶×2

hPC-PL-c 人類(lèi)胎盤(pán)周細(xì)胞(hPC-PL) 500,000cells 小鼠巨噬細(xì)胞MMa

磷酸化酪氨酸激酶受體A抗體規(guī)格 FASLG Protein Human 重組人 Fas Ligand / FASLG / CD95L 蛋白 (His 標(biāo)簽)

CNE-2 低分化細(xì)胞

ICOS Others Mouse 小鼠 ICOS / AILIM / CD278 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

BxPC-3人原位*腺癌細(xì)胞 BxPC-3 in situ pancreatic adenocarcinoma cells 1640+10% FBS

小鼠細(xì)胞(分泌促生長(zhǎng)激素分泌激素);AtT-20

人成纖維細(xì)胞( HCF) ( 5×105 ) GC-1, 鼠精原細(xì)胞 Mouse